MICROCIRCULATORY EFFECT OF FELODIPINE ON PATIENTS WITH ESSENTIAL-HYPERTENSION

被引:0
作者
KIESEWETTER, H [1 ]
JUNG, F [1 ]
ROTHER, T [1 ]
KOSCIELNY, J [1 ]
MROWIETZ, C [1 ]
RADTKE, H [1 ]
WENZEL, E [1 ]
机构
[1] UNIV CLIN SAARLAND,DEPT CLIN HAEMOSTASIOL & TRANSFUS MED,D-66421 HOMBURG,GERMANY
来源
CLINICAL HEMORHEOLOGY | 1995年 / 15卷 / 05期
关键词
ESSENTIAL HYPERTENSION; MICROCIRCULATION; CALCIUM ANTAGONIST; RHEOLOGY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this double blind placebo controlled crossover study is to show that apart from decreasing blood pressure felodipine improves microcirculation. 30 patients with essential hypertension and manifest microangiopathy were included. No patients dropped out on account of side effects although these occurred in the expected frequencies. The study phases each extended for a week (10 mg/d felodipine or respectively a placebo). Blood pressure, blood and serum values, nail fold capillary circulation and oxygen partial pressure in muscle were measured. The blood pressure in the placebo phase remained constant. The increase of erythrocyte velocity in cutaneous capillaries and oxygen partial pressure in muscle and the decrease of poorly supplied muscle areas caused by felodipine relevantly improved the microcirculation of skin and muscle by 50% and 30%. The vasomotor reserve increased by 50% owing to an antispastic effect of the substance. A theological effect was observed in the form of a decrease in plasma viscosity. Felodipine significantly and relevantly decreased by 10% the systolic and diastolic blood pressures. Apart from decreasing blood pressure Felodipine causes a relevant and significant global improvement of microcirculation in skin and skeletal muscle tissue.
引用
收藏
页码:707 / 713
页数:7
相关论文
共 50 条
  • [31] THE EFFECT OF CAPTOPRIL ON PERIPHERAL HEMODYNAMICS IN PATIENTS WITH ESSENTIAL-HYPERTENSION - COMPARISON BETWEEN ORAL AND SUBLINGUAL ADMINISTRATION
    LONGHINI, C
    ANSANI, L
    MUSACCI, GF
    MELE, D
    VACCARI, M
    BARACCA, E
    SGOBINO, P
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1990, 4 (03) : 751 - 754
  • [32] THE KIDNEY AND ESSENTIAL-HYPERTENSION - A LINK TO OSTEOPOROSIS
    MACGREGOR, GA
    CAPPUCCIO, FP
    [J]. JOURNAL OF HYPERTENSION, 1993, 11 (08) : 781 - 785
  • [33] PLATELET VOLUME IS NOT INCREASED IN ESSENTIAL-HYPERTENSION
    BATH, PMW
    CARNEY, C
    MARKANDU, ND
    MACGREGOR, GA
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1994, 8 (06) : 457 - 459
  • [34] ROLE OF ANGIOTENSINOGEN IN THE GENETICS OF ESSENTIAL-HYPERTENSION
    HATA, A
    [J]. LIFE SCIENCES, 1995, 57 (26) : 2385 - 2395
  • [35] ESSENTIAL-HYPERTENSION AND DIABETES-MELLITUS
    DIETZE, G
    WICKLMAYR, M
    RETT, K
    MEHNERT, H
    [J]. MEDIZINISCHE WELT, 1992, 43 (03): : 234 - 237
  • [36] CARDIOVASCULAR EFFECTS OF NISOLDIPINE IN ESSENTIAL-HYPERTENSION
    BLAU, A
    HERZOG, D
    HERZ, I
    BATTLER, A
    SHECHTER, P
    ELIAHOU, HE
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1994, 30 (02): : 139 - 145
  • [37] MICROVASCULAR FUNCTION IN HUMAN ESSENTIAL-HYPERTENSION
    SHORE, AC
    TOOKE, JE
    [J]. JOURNAL OF HYPERTENSION, 1994, 12 (07) : 717 - 728
  • [38] ENALAPRIL AND HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION - A REVIEW
    MALINI, PL
    [J]. ADVANCES IN THERAPY, 1993, 10 (06) : 253 - 262
  • [39] COMBINATION OF NIFEDIPINE AND DOXAZOSIN IN ESSENTIAL-HYPERTENSION
    DONNELLY, R
    ELLIOTT, HL
    MEREDITH, PA
    HOWIE, CA
    REID, JL
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (04) : 479 - 486
  • [40] HLA ANTIGENS IN BORDERLINE AND ESSENTIAL-HYPERTENSION
    TITKOV, YS
    ZISKINA, RA
    TEMIROV, AA
    GYBLADZE, DV
    BUBNOVA, LN
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (10) : 885 - 887